NasdaqGS - Nasdaq Real Time Price USD

Progyny, Inc. (PGNY)

27.53 -4.97 (-15.29%)
At close: May 10 at 4:00 PM EDT
27.92 +0.39 (+1.42%)
After hours: May 10 at 7:52 PM EDT
Loading Chart for PGNY
DELL
  • Previous Close 32.50
  • Open 24.40
  • Bid 27.50 x 400
  • Ask 27.55 x 700
  • Day's Range 24.40 - 27.91
  • 52 Week Range 23.90 - 44.95
  • Volume 8,995,017
  • Avg. Volume 1,033,436
  • Market Cap (intraday) 2.646B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 45.13
  • EPS (TTM) 0.61
  • Earnings Date Aug 1, 2024 - Aug 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 47.13

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

www.progyny.com

563

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PGNY

Performance Overview: PGNY

Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PGNY
25.95%
S&P 500
9.49%

1-Year Return

PGNY
27.17%
S&P 500
26.79%

3-Year Return

PGNY
46.76%
S&P 500
23.39%

5-Year Return

PGNY
--
S&P 500
72.79%

Compare To: PGNY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PGNY

Valuation Measures

Annual
As of 5/10/2024
  • Market Cap

    2.65B

  • Enterprise Value

    2.29B

  • Trailing P/E

    45.13

  • Forward P/E

    38.76

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.51

  • Price/Book (mrq)

    4.59

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.53%

  • Return on Assets (ttm)

    5.69%

  • Return on Equity (ttm)

    12.30%

  • Revenue (ttm)

    1.11B

  • Net Income Avi to Common (ttm)

    61.26M

  • Diluted EPS (ttm)

    0.61

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    371.83M

  • Total Debt/Equity (mrq)

    2.94%

  • Levered Free Cash Flow (ttm)

    172.68M

Research Analysis: PGNY

Company Insights: PGNY

Research Reports: PGNY

People Also Watch